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The aim of the work is synthesis of new polyfunctional magnetosensitive nanocomposites (NC) capable of the 
targeted delivery in the tumors of hepatocellular carcinoma and intrahepatic cholangiocarcinoma of a drug with 
chemotherapeutic mechanism of action – gemcitabine (GC), and deposition with the help of magnetic field, 
investigation of the basic physico-chemical properties of NC. Research direction includes synthesis of nanosized 
one-domain magnetite as a magnetically sensitive carrier, modification of its surface by carbon covering with the 
aim of stabilization and chemical functionalization, biofunctionalization of NC by GC immobilization. 
For investigation the following samples of NC were synthesized: Fe3O4, Fe3O4/HА, Fe3O4/С. The choice of 
samples is explained by the necessity to obtain a protective biocompatible cover with high adsorptive properties on a 
surface of magnetosensitive carrier. Carbonization of Fe3O4 surface and obtaining of Fe3O4/С NC was realized with 
the help of an organic substance – CS polygel (Carbomer 934). 
Adsorption of GC on a surface of magnetite and Fe3O4/HА, Fe3O4/С NC was carried out in aqueous medium in 
the concentration range С0 = 0.2–0.8 mg/L (g = 0.03 g, V = 5 mL, pH = 7.0) for 2 h in dynamic regime at room 
temperature. Amount of the adsorbed substance on a surface of NC was determined with the help of a 
spectrophotometer at λ = 268 nm from a calibration graph. 
Adsorption characteristics were studied for surfaces of the synthesized NC with respect to GC. The results 
obtained show the dependence of adsorption capacity of the investigated samples on chemical nature of their 
surface. An increase in equilibrium GC concentration leads to a growth of adsorption capacity of Fe3O4/HА NC, 
which becomes almost in saturation for Fe3O4 and Fe3O4/С NC. The surfaces of NC researched are characterized by 
rather like values of adsorption parameters (А = 25–30 mg/g), which may be caused by similar nature of adsorption 
centers of their surfaces and adsorption mechanisms. GC extraction extent R (%) is 25–30 %. 
Magnetic properties of NC with adsorbed gemcitabine Fe3O4/GC, Fe3O4/HА/GC, Fe3O4/С/GC were investigated 
with the help of a laboratory vibration magnetometer. An idea of the investigations is based on the use of an 
ensemble of superparamagnetic carriers as a probe for determination of parameters and control of core-shell type 
nanostructures with complex composition. Hysteresis loops were measured for magnetite particles, and NC with 
immobilized GC. It has been determined by the magnetic granulometry methods that the thickness of GC shell in the 
composition of Fe3O4/GC NC is (2.4±0.1) nm. Considering the thickness of GC layer is equal to 2.4 nm in all the 
studied nanostructures, we have found the value of thickness of hydroxyapatite layer in the structure of 
Fe3O4/HА/GC NC (3.5±0.1 nm), and the thickness of C layer in Fe3O4/С/GC NC (3.2±0.1 nm). 
The obtained data may be useful in creation of medical magnetocarried nanosystems of targeted delivery and 
adsorptive materials for application in oncotherapy. 
Keywords: gemcitabine, carbonization, hydroxyapatite, carbon coatings, surface, magnetite, magnetically 
sensitive nanocomposites, adsorption 
 
In works [1–10] we formulated a concept, 
created experimental samples, investigated and 
patented magnetically sensitive nanocomposites 
(NC) with multilevel hierarchical nano-
architecture and functions of biomedical 
nanorobots: recognition of microbiologic objects 
in biological media; targeted delivery of drugs to 
specific cells and organs, accumulation of 
therapeutic doses and deposition; complex 
therapy by chemo-, immune-, radiation neutron 
capture-, hyperthermic-, photodynamic methods 
and diagnostics in real time regime. 
As known, the targeted delivery and 
deposition of drug carriers in tumor area by 
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magnetic field give a possibility to decrease the 
total therapeutic dose of cytotoxic drugs 
considerably and, respectively, reduce to a 
minimum toxico-allergic reactions of an 
organism, and the use of local hyperthermia 
makes it possible, in principle, to carry out 
therapy of cancer diseases without application of 
chemical preparations [3–10].  
The outlined theme investigations are goal-
directly and systematically carrying out in 
collaboration by research workers of 
O.O. Chuiko Institute of Surface Chemistry, 
NAS of Ukraine, and R.E. Kavetsky Institute of 
Experimental Pathology, Oncology and 
Radiobiology of NAS of Ukraine [1–5, 11–15]. 
Up to this time, with the use of magnetosensitive 
NC, the new native oncological drug «Feroplat» 
was developed for application in clinical 
practices in treatment of malignant neoplasms, as 
well as the technology of its manufacture. 
«Feroplat» is a conjugate of magnetic fluid 
nanoparticles with cisplatin. It is a standardized 
remedy for increase in effectiveness of 
chemotherapy and overcoming of medicament 
resistance of malignant neoplasms, purposed for 
delivery of a cytostatic agent immediately into 
tumor tissue, which ensures its maximal coming 
into cells and promotes an increase in 
therapeutical effect. Its capability to selective 
accumulation in tumor improves antitumor effect 
of cisplatin, so increasing a biological safety 
level. Unlike the known chemotherapy drugs, 
“Feroplat” is more active with respect to tumors 
that are resistant to cisplatin, and proves less 
toxicity for normal cells. It has no analog in the 
world [16, 17]. 
This work continues our previous 
investigations. Its aim is the synthesis of new 
polyfunctional magnetosensitive nanostructures 
capable of the targeted delivery in the tumors of 
hepatocellular carcinoma (HCC) and intrahepatic 
cholangiocarcinoma (ICC) of drug with 
chemotherapeutic mechanism of action – 
gemcitabine, and deposition by the help of 
magnetic field with the additional functions of 
hyperthermic therapy and magnetic resonance 
imaging diagnostics in real time regime. 
As known [18], HCC is a highly lethal kind 
of cancer. HCC is the second on frequency 
among the most expanded death reasons with 
cancer in the world – 745 000 patients are dead 
with this disease every year. HCC morbidity 
continues to increase, for instance in USA during 
the last thirty years the morbidity and mortality 
through HCC has tripled. The approaches of 
HCC treatment depend on the stage of disease to 
a moment of giving the diagnosis and on 
accessibility of complex therapy methods. 
However, the disease in late stages is 
problematic, its treatment is expensive and 
effective only with respect to increase in index of 
«qualitatively ensured life years». Prognosis with 
HCC is usually quite unfavourable.  
The modern variants of HCC treatment, such 
as surgical resection of liver, transplantation of 
liver and locoregional therapy, including 
radiofrequency ablation and transarterial 
chemoembolization, are limited by very early 
stages of disease and can not prevent relapse. 
Moreover, most of patients (> 80 %) are at the 
last or non-operable stages of cancer, and the 
effective variants for treatment of such patients 
are practically absent. For such cases, the 
localized and systematic radiotherapy was 
applied simultaneously with chemotherapy, but 
with limited success. 
ICC is a malignant tumor of bile ducts [19]. 
The basic method of ICC treatment is operative. 
A total surgical ablation of tumor can potentially 
be used for ICC treatment, but prognosis keeps 
unfavourable because of frequent relapses and 
metastasis of tumors after operation. 
Chemotherapy and radiotherapy are used in 
complex with surgical method or as palliative 
treatment.  
As cleared from the said, HCC and ICC are 
very heavy diseases, and perspectives of 
treatment are quite non-optimistic. However, in 
the specialized research-medical centers of the 
developed countries, the goal-oriented 
investigations are carried out with the aim of 
search for the ways of overcoming the problem. 
So, for example, in one of the approaches chosen 
in the Department of Gastroenterology, 
Hepatology and Endocrinology of Hannover 
Medical School (MHH), Hannover, Germany, it 
is planned the use of magnetosensitive 
nanocomposites modified with chemo- and 
immunotherapeutical drugs and local methods of 
therapy [20–22].  
The said data show that the task of synthesis 
of new polyfunctional magnetosensitive 
nanostructures capable of the targeted delivery 
into HCC and ICC tumors of a drug with 
chemotherapeutic mechanism of action is actual 
from both scientific and practical points of view. 
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EXPERIMENTAL TECHNIQUES 
In this work, gemcitabine (GC) was chosen 
as a drug of the chemotherapeutic mechanism of 
action. Gemcitabine is a cytotoxic drug, an 
antimetabolite from the group of pyrimidine 
antagonists. The molecular formula is 
C9H11F2N3O4·HCl, molecular weight 299.66, the 




The drug exhibits cyclospecificity acting on 
cells in the phases S and G1/S. Gemcitabine is 
metabolised inside the cell under the action of 
nucleoside kinases with the formation of active 
diphosphate and triphosphate nucleosides. 
Diphosphate nucleosides inhibit ribonucleotide 
reductase, that acts as a single catalyst for 
reactions, leading to the formation of 
deoxynucleoside triphosphates, necessary for 
DNA synthesis. Triphosphate nucleosides 
compete actively with deoxycytidine 
triphosphate embedded in the DNA molecule 
and RNA. After embedding intracellular 
metabolites of gemcitabine into the DNA chain, 
another additional nucleotide is added to its 
growing strands. As a result, complete inhibition 
occur of further DNA synthesis and programmed 
lysis of the cell, known as apoptosis. Common 
side effects include bone marrow suppression, 
liver and kidney problems, nausea, fever, rash, 
shortness of breath, and hair loss. GC belongs to 
the list of the basic medicines of the World 
Health Organization, the most effective and safe 
medicines needed in a health system, it is 
commonly used off-label to treat 
cholangiocarcinoma and other biliary tract 
cancers [23, 24]. 
For investigation the following samples of 
magnetosensitive nanostructures were 
synthesized: ensembles of Fe3O4 nanoparticles, 
NC Fe3O4/HА, Fe3O4/С based on them. The 
choice of samples is explained by the necessity 
to obtain a protective biocompatible cover with 
high adsorptive properties on a surface of 
magnetosensitive carrier. 
Synthesis of magnetite. In the work we used 
the spread method for obtaining of magnetite 
nanoparticles – liquid phase, in the base of which 
the process of co-precipitation of bi- and 
trivalent iron salts laid according to the reaction 
[6]: 
Fe2+ + 2Fe3+ + 8NH4OH  Fe3O4 + 4H2O + 8NH4+. 
The size of the obtained particles was from 3 
to 23 nm with the average size of 8–12 nm. 
Specific surface area of the synthesized 
magnetite was Ssp ~ 110 m2/g. As calculated 
from the data of thermogravimetric analysis, the 
concentration of surface hydroxyl groups was 
2.4 mmol/g. 
The synthesized magnetite is characterized 
by satisfactory magnetic characteristics: coercive 
force Hc = 55.0 Oe, saturation magnetization 
σs = 56.2 Gs·сm3/g, relative residual magne-
tization Mr/Ms = 0.2. Such characteristics are 
important for biomedical applications, for 
example in the targeted delivery of drugs 
through blood vessels of small diameter, in 
which aggregation of particles is quite 
undesirable. 
Hydroxyapatite cover was obtained on a 
surface of highly dispersed magnetite by sol-gel 
method according to the reaction stoichiometry:  
10Са(NO3)2 + 6(NH4)2HPO4 + 8NH3 + 2Н2О → 
→ Са10(PO4)6(ОН)2 + 20NH4NO3. 
For Са10(PO4)6(ОН)2 synthesis the necessary 
amount of components was calculated so that 
molar ratio Са : Р was within the limits of 
1.67 : 1.75 with excess of ammonia (рН = 11) 
[6]. The obtained samples were tested by the 
methods of XPS and XPA. From the data of XPS 
for the synthesized nanocomposite samples the 
ratio Са/Р was 1.6–1.7. It is close to the optimal 
stoichiometric value for hydroxyapatite 
(Са/Р = 1.67). As appreciated from Fe2p-/Fe3p-
line area ratio and from the increase in NC mass, 
thickness of hydroxyapatite layer on a surface of 
magnetite is ~ 4 nm. The specific surface area 
for Fe3O4/HА samples Ssp = 105 m2/g. 
Concentration of the surface hydroxyl groups is 
~ 2.2 mmol/g.  
Carbonization of Fe3O4 surface and 
obtaining of Fe3O4/С NC was realized by the 
help of an organic substance – CS polygel 
(Carbomer 934). 
Carbomers are the derivatives of acrylic 
acid, from which under certain conditions and by 
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use of certain methods one obtains gels used in 
pharmacology as the basis for soft, liquid and 
solid medical forms. They are ether of acrylic 
acid homopolymers crosslinked by allyl sucrose, 
allyl pentaerythritol or divinyl glycol. Molecular 
mass of these polymers was theoretically 
calculated to be within the limits from 700000 to 
3–4 milliards, however methods for 
determination of the real molecular mass are 
absent. The repeated fragment (–СН2-СН-СООH) 
has molecular mass from 72 to 78, containing 
from 56 to 68 % of carboxyl groups as calculated 
for onto the dry substance [25]. 
The nanodispersed magnetite (mass 
g = 0.5 mg) was impregnated with 3 % solution 
of CS polygel (Carbomer 934) (V = 5 mL) in the 
distilled water at room temperature. After drying 
at 115 °C, a matrix was obtained with the 
adsorbed organic substance and roasted at 
400 °C for 2 h in argon flow. Specific surface 
area of Fe3O4/С samples was Ssp = 59 m2/g. 
The experimental results show that the 
process of carbonization of magnetosensitive 
nanocomposites is optimally carried out at 
400 °C for 2 h. 
Specific surface area of the samples was 
determined by nitrogen thermal desorption by 
means of a KELVIN 1042 device from 
«COSTECH Instruments». NP size was 
appreciated by formula DBET = 6/(ρSBET), where 
ρ is the density of NP material, SBET is the value 
of specific surface area calculated according the 
polymolecular adsorption theory of Brunauer, 
Emmett and Teller (BET). 
Calculation of the concentration of hydroxyl 
groups on a surface of nanostructures was 
determined from the data of thermogravimetric 
analysis using a derivatograph Q–1500. 
Adsorption of GC on a surface of magnetite 
and Fe3O4/HА, Fe3O4/С nanocomposites was 
carried out in aqueous medium in the 
concentration range С0 = 0.2–0.8 mg/L 
(g = 0.03 g, V = 5 mL, pH = 7.0) for 2 h in 
dynamic regime at room temperature. The 
amount of the adsorbed substance on a surface of 
nanocomposites was determined by the help of a 
spectrophotometer at λ = 268 nm from a 
calibration graph. The calibration graph was 
obtained from UV- spectrophotometric data. 
Adsorption capacity of the nanostructures А 
(mg/g) we calculated by formula: 
А = (С0 –Сeq)·V/m, 
where: С0 and Сeq are concentration of the initial 
solution and the solution after adsorption (mg/L), 
V is volume of the solution (mL), m is mass of 
the sorbent (g).  
Extraction extent R (%) was determined by 
formula: R, % = [(С0 – Сeq)/С0]·100. 
Magnetic properties of the composites with 
adsorbed gemcitabine Fe3O4/GC, Fe3O4/HА/GC, 
Fe3O4/С/GC were investigated by the help of a 
laboratory vibration magnetometer. 
RESULTS AND DISCUSSION 
Adsorption characteristics were studied for 
surfaces of the synthesized nanocomposites with 
respect to gemcitabine. Results of the obtained 
isotherms of GC adsorption are shown in 
Fig. 1, a, b, c. 
The results obtained show dependence of 
adsorption capacity of the investigated samples 
on chemical nature of their surface. An increase 
in equilibrium GC concentration sets off for 
adsorption saturation of Fe3O4/HА surface, with 
Fe3O4 and Fe3O4/С almost becoming in 
saturation. 
On a surface of Fe3O4/HА and Fe3O4/С 
composites at small concentrations, a weak 
interaction with a surface is observed, then 
beginning to increase sharply with growing 
concentration of adsorbate.  
The surfaces of NC researched are 
characterized by rather close values of 
adsorption parameters (А = 25–30 mg/g). It may 
be caused by similar nature of adsorption centers 
of their surfaces and adsorption mechanisms. 
Extraction extent R (%) is 25–30 % (Table 1). 
 
Table 1. Characteristics of gemcitabine adsorption 
on a surface of nanostructures under the 
conditions: С0 = 0.8 mg/mL, g = 0.03 g, 
V = 5 mL, pH = 7.0 
Nanostructure А, mg/g R, % 
Fe3O4 25.8 25.3 
Fe3O4/С 30.0 29.0 
Fe3O4/HА 30.5 24.8 
 
Experimental results show that the 
synthesized nanocomposites are promising for 
application as adsorption materials in 
intracorporal (enterosorption) and extracorporal 
detoxification.  
Magnetic properties of the synthesized 
nanostructures were investigated by techniques 
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[24, 25]. An idea of the investigations is based 
on the use of a superparamagnetic carrier as a 
probe for determination of parameters and 
control of complex composition nanostructures. 
Hysteresis loops measured for magnetite 
particles and composites with immobilized 
gemcitabine are shown in Fig. 2 (σ is specific 
magnetization, H – magnetic field strength). 
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Fig. 1. Isotherms of GC adsorption on a surface of magnetite (а) and composites Fe3O4/HА (b), Fe3O4/С (c) 
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Fig. 2. Hysteresis loops for magnetite (а), and composites Fe3O4/GC (b), Fe3O4/HА/GC (c), Fe3O4/С/GC (d) 
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The saturation magnetization of composite 
particles is sufficient for their use as the 
remedies of targeted delivery of drugs and the 
adsorption materials for intracorporal and 
extracorporal detoxification of an organism.  
The magnetic characteristics of magnetite 
and NC with adsorbed gemcitabine, obtained 
from the experimental hysteresis loops, are 
shown in Table 2. 
The values of σs indicate the presence of 
shell in the composites comparing to magnetite. 
Using the NC model of core – multilayer 
shell type and the calculation techniques 
[26, 27], the experimentally found values of 
average size of Fe3O4 cores (d0), specific 
saturation magnetization (σs), mass concentration 
of Fe3O4 in NC (αFe3O4exp), specific surface area 
of NC (Sspexp) we found the average value of 
thickness of adsorbed GC layer in the 
composition of Fe3O4/GC NC to be 2.4±0.1 nm. 
Considering the thickness of GC layer is equal to 
2.4 nm in all the studied nanostructures, we 
found the value of thickness of hydroxyapatite 
layer in the structure of Fe3O4/HА/GC NC 
(3.5 ± 0.1 nm; in our opinion, this is 
satisfactorily coordinated with the value ~ 4 nm 
[27]) and the thickness of C layer in Fe3O4/С/GC 
NC (3.2 ± 0.1 nm). 
 
 
Table 2. Magnetic characteristics of magnetite and composites with adsorbed gemcitabine 




emu/g σr, emu/g σr/σs αFe3O4
calc, % 
1 Fe3O4 0.081(7) 60.1 58.4 7.28 0.121 100 
2 Fe3O4/GC 0.079(9) 55.8 54.2 5.66 0.101 92.8 
3 Fe3O4/HА/GC 0.085(9) 14.2 13.5 4.16 0.118 23.6 
4 Fe3O4/С/GC 0.101(3) 10.2 9.7 3.85 0.114 17.1 
Hc, kOe is coercive force, σs, emu/g is specific saturation magnetization, σH=8 kOe, emu/g is specific magnetization in the field of 8 kOe, σr, emu/g is residual specific magnetization, σr/σs is 




We note that using techniques [26, 27] one 
can calculate: density of the shell ρ, function 
h(d), where h, d are thickness values of the shell 
and diameter of Fe3O4 NP, respectively, specific 
surface area of the samples, as well as to find ρ 
and h(d) at which NC ensembles have the 
maximal specific surface area. Such data may be 
actual for analysis of medical magnetocarried 
systems promising for the use in oncotherapy.  
The data said show that the synthesized 
magnetocarried NC are promising for 
continuation of the goal-oriented investigations 
aimed at creation of a new nanotechnology for 
oncology, based on the use of polyfunctional 
nanostructures capable of the targeted delivery of 
chemotherapeutical drug gemcitabine and 
deposition. The principal capability to realize the 
additional functions of recognition of tumor 
cells, hyperthermic therapy and magnetic 
resonance imaging diagnostics in real time 
regime was substantiated in [6].  
CONCLUSIONS 
New polyfunctional magnetosensitive 
nanostructures were synthesized capable of the 
targeted delivery into tumors of hepatocellular 
carcinoma and intrahepatic cholangiocarcinoma 
of the drug with chemotherapeutic mechanism of 
action – gemcitabine. The processes of 
adsorption of gemcitabine from its solutions in a 
physiological liquid on a surface of magnetite 
and magnetically sensitive NC with various 
surface nature were investigated. Adsorption of 
gemcitabine is: A = 25–30 mg/g (С0 = 0.8 mg/mL, 
g = 30 mg, V = 5 mL). The quantity of GC on a 
surface of NC was determined by 
spectrophotometric method at λ = 268 nm 
according to the calibration graph. The magnetic 
properties of synthesized nanostructures were 
studied. From the data of magnetic 
measurements, the size parameters of 
nanocomposite components were determined. 
The synthesized magnetocarried NC are 
promising for creation of a new nanotechnology 
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for oncology, based on the use of polyfunctional 
nanostructures capable of recognizing of HCC 
and ICC tumors, the targeted delivery of drugs of 
the chemotherapeutic and immunotherapeutic 
mechanism of action on them, and deposition 
with additional functions of hyperthermic 
therapy and magnetic resonance imaging 
diagnostics in real time regime. 
Publications are based on the research 
provided by the grant support of the State Fund 






Синтез і властивості магніточутливих нанокомпозитів 
на основі магнетиту і гемцитабіну 
 
А.Л. Петрановська, М.В. Абрамов, Н.М. Опанащук, С.П. Туранська, Н.В. Кусяк, П.П. Горбик 
 
Інститут хімії поверхні ім. О.О. Чуйка Національної академії наук України 
вул. Генерала Наумова, 17, Київ, 03164, Україна, opanaschuknatalya@gmail.com 
Житомирський державний університет імені Івана Франка 
вул. В. Бердичівська 40, Житомир, 10008, Україна 
 
Метою роботи є синтез нових поліфункціональних магніточутливих нанокомпозитів (НК), здатних до 
цільової доставки в пухлини гепатоцелюлярної карциноми і внутрішньопечінкової холангіокарциноми 
лікарського препарату хіміотерапевтичного механізму дії гемцитабін (ГЦ) та депонування за допомогою 
магнітного поля, дослідження основних фізико-хімічних властивостей НК. Напрямок досліджень включає 
синтез нанорозмірного однодоменного магнетиту як магніточутливого носія, модифікування його поверхні 
вуглецевим покриттям задля стабілізації та хімічної функціоналізації, біофункціоналізацію НК шляхом 
іммобілізації ГЦ. 
Для досліджень синтезовано наступні зразки НК: Fe3O4, Fe3O4/ГА, Fe3O4/С. Вибір зразків пояснюється необхідністю отримання на поверхні магніточутливого носія захисного біосумісного покриття з високими 
адсорбційними властивостями. Карбонізацію поверхні Fe3O4 та отримання НК Fe3O4/С здійснювали за допомогою органічної речовини – полігеля CS (Карбомер 934). 
Адсорбцію ГЦ на поверхні магнетиту та НК Fe3O4/ГА, Fe3O4/С проводили у водному середовищі в діапазоні концентрацій С0 = 0.2–0.8 мг/мл (g = 0.03 г , V = 5 мл, pH = 7.0) протягом 2 год у динамічному режимі при кімнатній температурі. Кількість адсорбованої речовини на поверхні НК визначали за 
допомогою спектрофотометра при λ = 268 нм за калібрувальним графіком.  
Вивчено адсорбційні характеристики поверхонь синтезованих НК щодо ГЦ. Одержані результати 
свідчать про залежність адсорбційної ємності досліджених зразків від хімічної природи їх поверхні. 
Зростання рівноважної концентрації ГЦ призводить до збільшення адсорбційної ємності НК Fe3O4/ГА, яка для Fe3O4 та НК Fe3O4/С майже виходить на насичення. Поверхні досліджених НК характеризуються досить близькими значеннями адсорбційних параметрів (А = 25–30 мг/г), що може бути обумовлено 
подібною природою  адсорбційних центрів їх поверхонь та механізмів адсорбції. Ступінь вилучення ГЦ R (%) 
складає 25–30 %.  
Магнітні властивості НК з адсорбованим гемцитабіном Fe3O4/ГЦ, Fe3O4/ГА/ГЦ, Fe3O4/С/ГЦ досліджували за допомогою лабораторного вібраційного магнітометра. Ідея досліджень ґрунтується на 
використанні ансамбля суперпарамагнітних носіїв у якості зонда для визначення параметрів та контролю 
наноструктур типу ядро-оболонка складної будови. Виміряні петлі гістерезису частинок магнетиту та НК 
з іммобілізованим ГЦ. Методами магнітної гранулометрії встановлено, що товщина оболонки ГЦ у складі 
НК Fe3O4/ГЦ становить 2.4±0.1 нм. Вважаючи товщину шару ГЦ рівною 2.4 нм в усіх досліджених наноструктурах, знайдено значення товщини шару гідроксиапатиту в структурі НК Fe3O4/ГА/ГЦ 
(3.5±0.1 нм) та товщину шару С в НК Fe3O4/С/ГЦ (3.2±0.1 нм). Отримані дані можуть бути корисними при створенні лікарських магнітокерованих наносистем 
адресної доставки та адсорбційних матеріалів для використання в онкотерапії. 
Ключові слова: гемцитабін, карбонізація, гідроксиапатит, вуглецеві покриття, поверхня, магнетит, 
магніточутливі нанокомпозити, адсорбція 
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Целью работы является синтез новых полифункциональных магниточувствительных нанокомпозитов 
(НК) для адресной доставки в опухоли гепатоцеллюлярной карциномы и внутрипеченочной 
холангиокарциномы лекарственного препарата химиотерапевтического механизма действия гемцитабин 
(ГЦ) и депонирования с помощью магнитного поля, исследование основных физико-химических свойств НК. 
Направление исследований включает синтез наноразмерного однодоменного магнетита в качестве 
магниточувствительного носителя, модифицирование его поверхности углеродным покрытием для 
стабилизации и химической функционализации, биофункционализацию НК путем иммобилизации ГЦ. 
Для исследований синтезированы следующие образцы НК: Fe3O4, Fe3O4/ГА, Fe3O4/С. Выбор образцов 
объясняется необходимостью получения на поверхности магниточувствительного носителя защитного 
биосовместимого покрытия с высокими адсорбционными свойствами. Карбонизацию поверхности Fe3O4 и получение НК Fe3O4/С осуществляли с помощью органического вещества – полигеля CS (Карбомер 934). Адсорбцию ГЦ на поверхности магнетита и НК Fe3O4/ГА, Fe3O4/С проводили в водной среде в диапазоне концентраций С0 = 0.2–0.8 мг/мл (g = 0.03 г , V = 5мл, pH = 7.0) в течение 2 ч в динамичном режиме при комнатной температуре. Количество адсорбированного вещества на поверхности НК определяли с 
помощью спектрофотометра (λ = 268 нм) по калибровочному графику.  
Изучены адсорбционные характеристики поверхностей синтезированных НК по отношению к ГЦ. 
Полученные результаты свидетельствуют о зависимости адсорбционной емкости исследованных образцов 
от химической природы их поверхности. Рост равновесной концентрации ГЦ приводит к увеличению 
адсорбционной емкости НК Fe3O4/ГА, а для наноструктур Fe3O4 и Fe3O4/С – близка к насыщению. Поверхности исследованных НК характеризуются достаточно близкими значениями адсорбционных 
параметров (А = 25–30 мг/г), что может быть обусловлено подобной природой адсорбционных центров их 
поверхностей и механизмов адсорбции. Степень извлечения ГЦ R (%) составляет 25–30 %. 
Магнитные свойства НК с адсорбированным гемцитабином Fe3O4/ГЦ, Fe3O4/ГА/ГЦ, Fe3O4/С/ГЦ исследовали с помощью лабораторного вибрационного магнитометра. Идея исследований основывается на 
использовании ансамбля суперпарамагнитных носителей в качестве зонда для определения параметров и 
контроля НК типа ядро-оболочка сложного строения. Измерены петли гистерезиса частиц магнетита и 
НК с иммобилизованным ГЦ. Методами магнитной гранулометрии установлено, что толщина оболочки ГЦ 
в составе НК Fe3O4/ГЦ составляет 2.4±0.1 нм. Принимая толщину слоя ГЦ равной 2.4 нм во всех исследованных НК, найдено значение толщины слоя гидроксиапатита в структуре НК Fe3O4/ГА/ГЦ 
(3.5±0.1 нм) и толщину слоя С в НК Fe3O4/С/ГЦ (3.2±0.1 нм). Полученные данные могут быть полезны при создании лекарственных магнитоуправляемых наносистем 
адресной доставки и адсорбционных материалов для использования в онкотерапии. 
Ключевые слова: гемцитабин, карбонизация, гидроксиапатит, углеродные покрытия, поверхность, 
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